AUGMENT PHASE III STUDY: LENALIDOMIDE/RITUXIMAB (R2) IMPROVED EFFICACY OVER RITUXIMAB/PLACEBO IN RELAPSED/REFRACTORY FOLLICULAR PATIENTS IRRESPECTIVE OF POD24 STATUS
Hematological Oncology | June 12, 2019 | Volume: 37 | Issue: S2 | Pages: 114-115
10.1002/hon.75_2629